| Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses AB Vogel, L Lambert, E Kinnear, D Busse, S Erbar, KC Reuter, L Wicke, ... Molecular Therapy 26 (2), 446-455, 2018 | 394 | 2018 |
| Silver resistance in Gram-negative bacteria: a dissection of endogenous and exogenous mechanisms CP Randall, A Gupta, N Jackson, D Busse, AJ O'neill Journal of Antimicrobial Chemotherapy 70 (4), 1037-1046, 2015 | 270 | 2015 |
| Interferon-induced protein 44 and interferon-induced protein 44-like restrict replication of respiratory syncytial virus DC Busse, D Habgood-Coote, S Clare, C Brandt, I Bassano, M Kaforou, ... Journal of Virology 94 (18), 2020 | 72 | 2020 |
| Interferon-induced transmembrane protein 1 restricts replication of viruses that enter cells via the plasma membrane SE Smith, DC Busse, S Binter, S Weston, CD Soria, BM Laksono, S Clare, ... Journal of virology 93 (6), 2019 | 61 | 2019 |
| The switch between acute and persistent paramyxovirus infection caused by single amino acid substitutions in the RNA polymerase P subunit DF Young, EB Wignall-Fleming, DC Busse, MJ Pickin, J Hankinson, ... PLoS pathogens 15 (2), e1007561, 2019 | 25 | 2019 |
| A single-stranded oligonucleotide inhibits toll-like receptor 3 activation and reduces influenza A (H1N1) infection C Poux, A Dondalska, J Bergenstråhle, S Pålsson, V Contreras, C Arasa, ... Frontiers in immunology 10, 2161, 2019 | 21 | 2019 |
| Recombinant haemagglutinin derived from the ciliated protozoan Tetrahymena thermophila is protective against influenza infection K Jawinski, M Hartmann, C Singh, E Kinnear, DC Busse, A Ciabattini, ... Frontiers in immunology 10, 2661, 2019 | 2 | 2019 |
Dr John S TregoningImperial College LondonVerified email at imperial.ac.uk
